Isofol Medical AB (publ) (STO:ISOFOL)
Sweden · Delayed Price · Currency is SEK 0.8805
-0.0260 (-2.87%)
Aug 1, 2025, 5:29 PM CET
Intra-Cellular Therapies Market Cap
Isofol Medical AB has a market cap or net worth of 247.51 million as of August 1, 2025. Its market cap has decreased by -21.89% in one year.
Market Cap
247.51M
Enterprise Value
165.41M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.88
Market Cap Chart
Since April 4, 2017, Isofol Medical AB's market cap has decreased from 853.32M to 247.51M, a decrease of -70.99%. That is a compound annual growth rate of -13.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 247.51M | -30.97% |
| Dec 30, 2024 | 358.56M | 204.11% |
| Dec 29, 2023 | 117.91M | -1.35% |
| Dec 30, 2022 | 119.52M | -91.99% |
| Dec 30, 2021 | 1.49B | -36.06% |
| Dec 30, 2020 | 2.33B | 260.50% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 4, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 96.35B |
| Sectra AB | 71.68B |
| Getinge AB | 53.34B |
| Camurus AB | 41.80B |
| Medicover AB | 41.67B |
| Asker Healthcare Group AB | 38.24B |
| Bonesupport Holding AB | 22.17B |
| AddLife AB | 21.05B |